Upregulation of K <sub>2P</sub> 3.1 K <sup>+</sup> Current Causes Action Potential Shortening in Patients With Chronic Atrial FibrillationConstanze Schmidt, Dierk Thomas, Felix Wiedmann et al.|Circulation|2015Cited by 195
Acute canagliflozin treatment protects against in vivo myocardial ischemia–reperfusion injury in non-diabetic male rats and enhances endothelium-dependent vasorelaxationAlex Ali Sayour, Gábor Szabó|Journal of Translational Medicine|2019Cited by 131
Patients at low surgical risk as defined by the Society of Thoracic Surgeons Score undergoing isolated interventional or surgical aortic valve implantation: in-hospital data and 1-year results from the German Aortic Valve Registry (GARY)Raffi Bekeredjian, Thomas Walther, Gábor Szabó et al.|European Heart Journal|2018Cited by 125
S100A1 Gene Therapy Preserves in Vivo Cardiac Function after Myocardial InfarctionSven T. Pleger, Patrick Most, Mirko Völkers et al.|Molecular Therapy|2005Cited by 82
Oral treatment with a zinc complex of acetylsalicylic acid prevents diabetic cardiomyopathy in a rat model of type-2 diabetes: activation of the Akt pathwaySevil Korkmaz‐Icöz, Gábor Szabó|Cardiovascular Diabetology|2016Cited by 36